JPRN-UMIN000007539已完成未知
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR Study - Remission induction by Raising the dose of Remicade in RA Extension study (RRRR-EX Study)
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 108 人开始时间: 2012年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who discontinued IFX treatment prior to 54 week from the first administration of IFX in the RRRR Study 2) Patients who are inadequate to enter this trial due to the other reasons by physician's judgments
研究者
相似试验
招募中
不适用
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, through application of musculoskeletal ultrasonography and treatment for periodontal disease, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014886agasaki University Hospital250
招募中
不适用
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014881agasaki University Hospital250
进行中（未招募）
1 期
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritisRheumatoid arthritisEUCTR2016-002908-15-NLSint Maartenskliniek140
已完成
不适用
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritisJPRN-UMIN000016950Osaka Medical College50
招募中
不适用
Refractory Rheumatoid ArthritisM05Seropositive rheumatoid arthritisDRKS00005807Abteilung für RheumatologieMedizinische Universität Wien219